Tech Company Financing Transactions

Alvine Pharmaceuticals Funding Round

Panorama Capital, Flagship Pioneering and InterWest Partners joined a $21.5 million Series A funding round for Alvine Pharmaceuticals. The round was announced on 9/15/2009.

Transaction Overview

Company Name
Alvine Pharmaceuticals
Announced On
9/15/2009
Transaction Type
Venture Equity
Amount
$21,500,000
Round
Series A
Investors

Panorama Capital (Lead Investor) (Gaurav Aggarwal)

Flagship Pioneering

InterWest Partners

Prospect Venture Partners

Sofinnova Ventures (Michael Powell)

Proceeds Purpose
This funding will support the continued development of ALV003 as an innovative protease therapy for the treatment of celiac disease, and further our goal to be the leading company in this space.

Company Information

Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
75 Shoreway Rd. B
San Carlos, CA 94070
USA
Phone
(650) 632-1645
Website
www.alvinepharma.com
Email Address
Not Recorded
Overview
Alvine Pharmaceuticals, Inc., is a biopharmaceutical company dedicated to developing and commercializing therapeutics for the treatment of Celiac sprue.
Profile
Alvine Pharmaceuticals LinkedIn Company Profile
Social Media
Alvine Pharmaceuticals Company Twitter Account
Company News
Alvine Pharmaceuticals News
Facebook
Alvine Pharmaceuticals on Facebook
YouTube
Alvine Pharmaceuticals on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Abhay Joshi
  Abhay Joshi LinkedIn Profile  Abhay Joshi Twitter Account  Abhay Joshi News  Abhay Joshi on Facebook
Chief Medical Officer
Daniel Adelman
  Daniel Adelman LinkedIn Profile  Daniel Adelman Twitter Account  Daniel Adelman News  Daniel Adelman on Facebook
VP - Finance
David Southern
  David Southern LinkedIn Profile  David Southern Twitter Account  David Southern News  David Southern on Facebook
VP - Marketing
Kirk Essenmacher
  Kirk Essenmacher LinkedIn Profile  Kirk Essenmacher Twitter Account  Kirk Essenmacher News  Kirk Essenmacher on Facebook
VP - Regulatory Affairs
Henk Kocken
  Henk Kocken LinkedIn Profile  Henk Kocken Twitter Account  Henk Kocken News  Henk Kocken on Facebook
VP - Sales
James Watson
  James Watson LinkedIn Profile  James Watson Twitter Account  James Watson News  James Watson on Facebook

 

 

Browse more venture capital transactions:

Prev: 9/15/2009: Ruckus Wireless venture capital transaction
Next: 9/15/2009: Accept Software venture capital transaction

 

Share this article

 

Where The Data Comes From

We do our best to report on all VC transactions involving tech companies. VC transactions on this site are sourced from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.

 

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary

 

Copyright © 2001-2024. Gaebler Ventures. All rights reserved.